Holen Sie sich die Stockscreener-App
708.45
0.74%
-5.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Does IDEXX Laboratories Inc. fit your quant trading modelAnalyst Downgrade & Safe Entry Zone Identification - newser.com
Building trade automation scripts for IDEXX Laboratories Inc.2025 Biggest Moves & Precise Buy Zone Identification - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveOptions Play & Free Growth Oriented Trading Recommendations - newser.com
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
Will IDEXX Laboratories Inc. stock recover after recent drop2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
What analyst consensus implies for IDEXX Laboratories Inc. (IX1) stockQuarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockPortfolio Growth Summary & AI Driven Stock Reports - newser.com
Is IDEXX Laboratories Inc. stock supported by strong cash flowsCEO Change & Accurate Intraday Trade Tips - newser.com
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Earnings Beat: IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Will earnings trigger a reversal in IDEXX Laboratories Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
Is IDEXX Laboratories Inc. stock a safe buy before earningsJuly 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Is IDEXX Laboratories Inc. stock ready for a breakoutTrade Ideas & Daily Stock Momentum Reports - newser.com
IDEXX Laboratories Hits New 52-Week High of $734.64, Up 42.24% - Markets Mojo
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $775.00 - MarketBeat
Blue Barn Wealth LLC Takes $225,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Grows Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bridgewater Advisors Inc. Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
415 Shares in IDEXX Laboratories, Inc. $IDXX Acquired by Fullcircle Wealth LLC - MarketBeat
Bank of Montreal Can Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Arkadios Wealth Advisors Acquires New Shares in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX outlines 9.6%–10.3% revenue growth outlook for 2025 amid robust CAG Diagnostics expansion - MSN
Trend analysis for IDEXX Laboratories Inc. this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UBS Maintains IDEXX Laboratories (IDXX) Neutral Recommendation - Nasdaq
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average - sharewise.com
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail
IDEXX Laboratories (IDXX) Sees Target Price Raised by Morgan Sta - GuruFocus
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) - Yahoo Finance
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $805 - 富途牛牛
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $750 - 富途牛牛
UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories (NASDAQ:IDXX) Hits New 12-Month High Following Earnings Beat - MarketBeat
World Investment Advisors Takes $456,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Releases FY 2025 Earnings Guidance - MarketBeat
Idexx Laboratories stock reaches 52-week high at $693.00 By Investing.com - Investing.com Australia
IDEXX Laboratories (NASDAQ:IDXX) Posts Quarterly Earnings Results, Beats Estimates By $0.26 EPS - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2025 Earnings Call Transcript - Insider Monkey
Bank of New York Mellon Corp Raises Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
A Fresh Look at IDEXX Laboratories (IDXX) Valuation After Raising Full-Year Growth Outlook - Yahoo Finance
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $775 to $830 - 富途牛牛
Fund Update: 16,825 IDEXX LABS (IDXX) shares added to KEYBANK NATIONAL ASSOCIATION|OH portfolio - Quiver Quantitative
Jefferies Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $805 From $765, Maintains Overweight Rating - MarketScreener
JPMorgan Adjusts Price Target on IDEXX Laboratories to $775 From $675, Maintains Overweight Rating - MarketScreener
BTIG Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $823 From $761, Maintains Outperform Rating - MarketScreener
Rothschild & Co Redburn Adjusts PT on IDEXX Laboratories to $700 From $670, Maintains Neutral Rating - MarketScreener
Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum - Yahoo Finance
BTIG Maintains IDEXX Laboratories (IDXX) Buy Recommendation - Nasdaq
0.51%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):